logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute

Small Cap•348 Employees•IPO 2008
Current Price
₹103.53
0.02 (0.02%)Updated
NSE :LOTUSEYE
BSE :532998
Sector :Health Care Providers & Services
Today's Range
99.5
₹103.53
indicator
106
52 Week Range
52W Low₹55.30
52W High₹147.00
₹103.53
indicator
Downside87.22%
Upside41.99%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹257.35 Cr
Market Cap
Total market value of company
P/E Ratio
381.89
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
4.07
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹0.35
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
0.61%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
2.79%
ROCE
Return on Capital Employed. >15% is good
Net Margin
1.34%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-6.71%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
4.10%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
-%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.06
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹28.85
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
0.00%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

0 points

    Weaknesses

    0 points

      Opportunities

      0 points

        Threats

        0 points

          Segment-wise Financial Analysis

          Fetching Financials...
          Fetching Balance Sheet...
          Fetching Cash Flow...

          Shareholding Pattern

          Loading shareholding data...

          Company Insider Trading Activity

          No insider trading data available

          Corporate Action

          Company Announcements

          Technical Analysis & Indicators

          Standard pivot points - most widely used

          Pivot Points (CLASSIC)

          LevelPriceDistance% Change
          R4₹119.52+₹15.99+15.44%
          R3₹113.02+₹9.49+9.17%
          R2₹109.51+₹5.98+5.78%
          R1₹106.52+₹2.99+2.89%
          PIVOT₹103.01-0.52-0.50%
          CURRENT₹103.53--
          S1₹87.02-₹16.51-15.95%
          S2₹93.52-₹10.01-9.67%
          S3₹96.51-₹7.02-6.78%
          S4₹100.02-₹3.51-3.39%
          CPR Levels
          Support
          Resistance
          S4
          S3
          S2
          S1
          | CPR |
          BC: N/AP: N/ATC: N/A
          R1
          R2
          R3
          R4
          indicator
          LTP: N/A
          PDH: N/A
          PDL: N/A
          ● Market Sentiment

          is trading CPR, indicating

          ● CPR Width

          CPR is

          ● Opening Range

          Day's range: ~

          ● Price Position

          Trading Inside opening range

          Delivery Volume Analysis & Trading Activity

          Latest Volume
          0.24L
          (13 Mar 2026)
          -32.0% vs avg
          Delivery %
          59.0%
          (13 Mar 2026)
          -1.7% vs avg
          Avg Volume (20D)
          0.35L
          (13 Feb - 13 Mar)
          20-day average
          Avg Delivery %
          60.7%
          (13 Feb - 13 Mar)
          Trend ↑
          Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

          Peer Comparison & Industry Benchmarking

          Quick Compare

          Largest by Market Cap
          Apollo Hospitals Enterprise Ltd
          1.09L ₹ Cr
          Best Profit Growth
          Apollo Hospitals Enterprise Ltd
          41.80 %
          Highest Dividend Yield
          Apollo Hospitals Enterprise Ltd
          0.38 %

          Peer Comparison

          Company Name
          APOLLOHOSP
          Apollo Hospitals Enterprise Ltd
          GPTHEALTH
          GPT Healthcare Ltd
          MAXIND
          Max India Ltd

          About

          LOTUSEYE

          Lotus Eye Hospital & Institute Ltd

          Lotus Eye Hospital and Institute Limited is a prominent specialty eye care hospital in India, established in 1989 and headquartered in Coimbatore. The hospital offers a comprehensive range of ophthalmic services, catering to diverse patient needs and encompassing various subspecialties.

          Their surgical services are extensive, including a wide array of refractive procedures such as ReLEx SMILE lasik, LASIK eye surgery, epilasik, and Intralase, alongside advanced cataract surgery techniques like robotic femto laser cataract surgery, phacoemulsification, micro incision cataract surgery (MICS), and small incision cataract surgery (SICS). They also perform a variety of corneal surgeries, including penetrating keratoplasty (PKP), deep anterior lamellar keratoplasty (DALK), and corneal patch grafts, as well as glaucoma surgeries like trabeculectomy and other procedures addressing conditions like pterygium and retinal detachments. The hospital also provides specialized pediatric eye care and squint surgery.

          Beyond surgical interventions, Lotus Eye Hospital offers a full spectrum of medical treatments. This includes injections for various retinal diseases (like Avastin, Lucentis, and Eylea), management of conditions such as keratoconus, glaucoma, diabetic retinopathy, uveitis, and neuro-ophthalmological disorders. They also address common issues like computer vision syndrome and binocular vision problems.

          The hospital's commitment extends beyond direct patient care. It operates an in-house eye bank, optical showroom, and pharmacy, providing patients with convenient access to essential resources. Furthermore, its commitment to education and research is evident through its operation of a research trust, offering a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program, contributing to the advancement of ophthalmic care in India.

          In summary, Lotus Eye Hospital and Institute Limited provides a holistic approach to eye care, integrating advanced surgical techniques, comprehensive medical treatments, supportive ancillary services, and educational initiatives to establish itself as a leading provider of ophthalmic services in India.

          COMPANY FACTS - LOTUSEYE

          Registered Address

          770/12 Avinashi Road,, Civil Aerodrome post,

          Coimbatore

          TAMIL NADU

          IN

          Tel: 914224229999

          Website:https://www.lotuseye.org/

          Investor Relations:https://www.lotuseye.org/about-us/investors/
          Company Details

          Group: Health Care Equipment & Services

          Sector: Health Care

          Industry: Health Care Providers & Services

          Exchange: NATIONAL STOCK EXCHANGE OF INDIA

          Employees: 348

          IPO Date: 11/07/2008

          MANAGEMENT - LOTUSEYE

          Ms. Kavetha Sundaramoorthy

          Chairman of the Board

          Dr. K.S. Ramalingam

          Chief Executive Officer, Additional Executive Director

          Mr. Ramanujam Reghunathan

          Chief Financial Officer

          Mr. M Achuth Menon

          Company Secretary, Compliance Officer

          Ms. Sangeetha Sundaramoorthy

          Managing Director, Executive Director

          Mr. Perumalsamy Mahendran

          Independent Director

          Dr. S. Natesan

          Additional Non-Executive Independent Director

          Mr. Karthik Veeramani

          Additional Non-Executive Independent Director

          Investor Questions Answered

          Lotus Eye Hospital & Institute Ltd (LOTUSEYE) Stock FAQs

          Get answers to the most common questions about Lotus Eye Hospital & Institute Ltd stock price, fundamentals, financial metrics, and investment analysis

          The current share price of Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is ₹103.53. Today, the stock has gained by ₹0.02 (0.02%), trading in a range of ₹99.5 to ₹106. The stock opened at ₹103.51 with a trading volume of 23,989 shares.
          Lotus Eye Hospital & Institute Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹257.35 crores, P/E ratio of 381.89, ROE of 0.61%, and ROCE of 2.79%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
          The 52-week high price of Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is ₹147, while the 52-week low is ₹55.3. Currently trading at ₹103.53, the stock is 52.6% away from its 52-week low and 29.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
          Whether to buy Lotus Eye Hospital & Institute Ltd stock at ₹103.53 depends on multiple factors. The stock is currently trading with a P/E ratio of 381.89 and P/B ratio of N/A. Today's performance shows a gain of 0.02%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
          Lotus Eye Hospital & Institute Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹103.53, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
          Lotus Eye Hospital & Institute Ltd's key financial metrics include: P/E Ratio: 381.89, P/B Ratio: N/A, ROE: 0.61%, ROCE: 2.79%, Dividend Yield: 0.00%, EPS: ₹0.35, Book Value: ₹28.85, Debt-to-Equity: 0.06, and Current Ratio: N/A. The company's market cap stands at ₹257.35 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
          Lotus Eye Hospital & Institute Ltd stock opened at ₹103.51 and is currently trading at ₹103.53, showing a gain of ₹0.02 (0.02%). The intraday high is ₹106 and low is ₹99.5. The trading volume stands at 23,989 shares, indicating moderate market participation today.
          Lotus Eye Hospital & Institute Ltd has a Price-to-Earnings (P/E) ratio of 381.89, which means investors are willing to pay ₹381.89 for every ₹1 of earnings. With an EPS of ₹0.35, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
          Lotus Eye Hospital & Institute Ltd has a market capitalization of ₹257.35 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹103.53) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
          Lotus Eye Hospital & Institute Ltd has a book value of ₹28.85 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹103.53, which is 258.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
          Lotus Eye Hospital & Institute Ltd has a Return on Equity (ROE) of 0.61% and Return on Capital Employed (ROCE) of 2.79%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
          Lotus Eye Hospital & Institute Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
          Lotus Eye Hospital & Institute Ltd has a debt-to-equity ratio of 0.06, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
          Lotus Eye Hospital & Institute Ltd has an Earnings Per Share (EPS) of ₹0.35, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹103.53 and P/E ratio of 381.89, investors are paying 381.89 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
          Lotus Eye Hospital & Institute Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
          Lotus Eye Hospital & Institute Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
          To analyze Lotus Eye Hospital & Institute Ltd stock, consider: 1) Fundamental Analysis - Review P/E (381.89), ROE (0.61%), debt-to-equity (0.06), and growth rates. 2) Technical Analysis - Check 52-week range (₹55.30 - ₹147.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹103.53) with book value (₹28.85) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
          The face value (or par value) of Lotus Eye Hospital & Institute Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹103.53 is 935x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
          Investing in Lotus Eye Hospital & Institute Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹55.30 - ₹147.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.06 indicates leverage. 4) Liquidity Risk - Based on trading volume of 23,989 shares. 5) Valuation Risk - P/E of 381.89 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
          Lotus Eye Hospital & Institute Ltd operates in the industry with key metrics: P/E ratio of 381.89, ROE of 0.61%, market cap of ₹257.35 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.06), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
          Target prices for Lotus Eye Hospital & Institute Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹103.53, with a 52-week range of ₹55.30 to ₹147.00. Based on fundamentals like P/E (381.89), ROE (0.61%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
          Consider selling Lotus Eye Hospital & Institute Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹103.53. 2) Fundamental Deterioration - Declining ROE (currently 0.61%), increasing debt (D/E: 0.06), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
          Tax implications for Lotus Eye Hospital & Institute Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.